76 related articles for article (PubMed ID: 28282719)
1. Evidence for the importance of personalized molecular profiling in pancreatic cancer.
Lili LN; Matyunina LV; Walker LD; Daneker GW; McDonald JF
Pancreas; 2014 Mar; 43(2):198-211. PubMed ID: 24518497
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Review: Personalized Medicine for Rare Disease Cancer Treatment.
Rajput DS; Gupta N; Singh S; Sharma B
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2023 Dec; 39():e20230008. PubMed ID: 38830754
[TBL] [Abstract][Full Text] [Related]
3. Illuminating the immunological landscape: mitochondrial gene defects in pancreatic cancer through a multiomics lens.
Chi H; Su L; Yan Y; Gu X; Su K; Li H; Yu L; Liu J; Wang J; Wu Q; Yang G
Front Immunol; 2024; 15():1375143. PubMed ID: 38510247
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics.
Sarah A; Dondi E; De Francia S
Expert Opin Drug Metab Toxicol; 2023; 19(11):733-739. PubMed ID: 37916644
[No Abstract] [Full Text] [Related]
5. The Genotype-Tissue Expression (GTEx) Project: Linking Clinical Data with Molecular Analysis to Advance Personalized Medicine.
Keen JC; Moore HM
J Pers Med; 2015 Feb; 5(1):22-9. PubMed ID: 25809799
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in pancreatic cancer treatment: a new frontier.
Thind K; Padrnos LJ; Ramanathan RK; Borad MJ
Therap Adv Gastroenterol; 2017 Jan; 10(1):168-194. PubMed ID: 28286568
[TBL] [Abstract][Full Text] [Related]
7. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
[TBL] [Abstract][Full Text] [Related]
8. Nutrition, Cancer and Personalized Medicine.
Flores-Pérez JA; de la Rosa Oliva F; Argenes Y; Meneses-Garcia A
Adv Exp Med Biol; 2019; 1168():157-168. PubMed ID: 31713171
[TBL] [Abstract][Full Text] [Related]
9. Personalized medicine: motivation, challenges, and progress.
Goetz LH; Schork NJ
Fertil Steril; 2018 Jun; 109(6):952-963. PubMed ID: 29935653
[TBL] [Abstract][Full Text] [Related]
10. Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations.
Calar K; Plesselova S; Bhattacharya S; Jorgensen M; de la Puente P
Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32610529
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics update in pancreatic cancer.
Puri A; Saif MW
JOP; 2014 Mar; 15(2):114-7. PubMed ID: 24618431
[TBL] [Abstract][Full Text] [Related]
12. Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype.
Yee NS
Adv Exp Med Biol; 2013; 779():91-143. PubMed ID: 23288637
[TBL] [Abstract][Full Text] [Related]
13. Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.
Fang Y; Yao Q; Chen Z; Xiang J; William FE; Gibbs RA; Chen C
Med Sci Monit; 2013 Oct; 19():916-26. PubMed ID: 24172537
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics and Personalized Medicine in Pancreatic Cancer.
Hosseini Bereshneh A; Morshedi F; Hematyar M; Kaki A; Garshasbi M
Acta Med Iran; 2017 Mar; 55(3):194-199. PubMed ID: 28282719
[TBL] [Abstract][Full Text] [Related]
15. Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.
de Wilde RF; Edil BH; Hruban RH; Maitra A
Nat Rev Gastroenterol Hepatol; 2012 Feb; 9(4):199-208. PubMed ID: 22310917
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
